Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Soares Seixas (Aveiro, Portugal), P. Serra (Aveiro, Portugal), M. Ferreira (Aveiro, Portugal), R. Aguiar (Aveiro, Portugal), P. Ferreira (Aveiro, Portugal). Criteria for PF-ILD in a cohort of patients with chronic hypersensitivity pneumonitis. 3538

Member's Comments

No comment yet.

Related content which might interest you: Prognostic factors in Korean patients with chronic hypersensitivity pneumonitis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Fibrosis score predicts mortality in patients with chronic hypersensitivity pneumonitis Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis Source: ERJ Open Res, 3 (3) 00016-2017; 10.1183/23120541.00016-2017 Year: 2017 Mortality risk prediction with ILD-GAP index in a portuguese chronic hypersensitivity pneumonitis cohort Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis Source: ERJ Open Res, 4 (3) 00043-2018; 10.1183/23120541.00043-2018 Year: 2018 Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Source: Virtual Congress 2020 – Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Year: 2020 Prognostic characteristics in chronic hypersensitivity pneumonitis. Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Occurrence of hypersensitivity to beryllium among patients with diagnosed sarcoidosis. Initial results Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Asthma and chronic idiopathic eosinophilic pneumonia (CIEP): a study of 52 patients Source: Eur Respir J 2001; 18: Suppl. 33, 5s Year: 2001 Clinical response to mepolizumab in patients with severe eosinophilic asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Prognostic factors in chronic hypersensitivity pneumonitis Source: Eur Respir Rev, 29 (156) 190167; 10.1183/16000617.0167-2019 Year: 2020 Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Clinical course in hypersensitivity pneumonitis: a review of 38 cases Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Incidence of allergic asthma in patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 232s Year: 2006 Squeaks in hypersensitivity pneumonitis: prevalence and clinical correlates Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin Year: 2019 Diagnosis, course and management of hypersensitivity pneumonitis Source: Eur Respir Rev, 31 (163) 210169; 10.1183/16000617.0169-2021 Year: 2022 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study. Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018